Radiation Oncology · 2013 · 22 citations · 19 references
MedicineOncologyRadiation OncologyMolecular OncologyRadiation BiophysicsRadiobiologyBiological Effects Of RadiationCancer Cell SignalingCellular Radiation ResponseFractionation EffectsRadiation SensitivityRadiation TherapyCell Cycle Control ProteinsCell Cycle DisturbanceCell Cycle InhibitionCellular RadiosensitivityNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentRadiotherapy ResistanceTumor Radiosensitivity
BACKGROUND: Radioresistance is the common cause for radiotherapy failure in non-small cell lung cancer (NSCLC), and the degree of radiosensitivity of tumor cells is different during different cell cycle phases. The objective of the present study was to investigate the effects of cell cycle redistribution in the establishment of radioresistance in NSCLC, as well as the signaling pathway of SH2 containing Tyrosine Phosphatase (SHP1). METHODS: A NSCLC subtype cell line, radioresistant A549 (A549S1), was induced by high-dose hypofractionated ionizing radiations. Radiosensitivity-related parameters, cell cycle distribution and expression of cell cycle-related proteins and SHP1 were investigated. siRNA was designed to down-regulate SHP1expression. RESULTS: Compared with native A549 cells, the proportion of cells in the S phase was increased, and cells in the G0/G1 phase were consequently decreased, however, the proportion of cells in the G2/M phase did not change in A549S1 cells. Moreover, the expression of SHP1, CDK4 and CylinD1 were significantly increased, while p16 was significantly down-regulated in A549S1 cells compared with native A549 cells. Furthermore, inhibition of SHP1 by siRNA increased the radiosensitivity of A549S1 cells, induced a G0/G1 phase arrest, down-regulated CDK4 and CylinD1expressions, and up-regulated p16 expression. CONCLUSIONS: SHP1 decreases the radiosensitivity of NSCLC cells through affecting cell cycle distribution. This finding could unravel the molecular mechanism involved in NSCLC radioresistance.
19
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Global Cancer Statistics, 2002
Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2005 · 18.4K citations · Full text
Lirong Peng, Jinying Ning, Ling Meng et al. · Journal of Cancer Research and Clinical Oncology · 2004 · 95 citations · Full text